Evidence map›Paper›PMID 38884364›Full record

ArticleTransfusion2024

Testosterone supplementation increases red blood cell susceptibility to oxidative stress, decreases membrane deformability, and decreases survival after cold storage and transfusion.

Johnson Tran, Rachael P Jackman, Marcus O Muench, Kelsey Hazegh, Scott-Wesley Bean, Kimberly A Thomas, Fang Fang, Grier Page, Kim O'Connor, Nareg H Roubinian and 2 more

Abstract read
In one paragraph

Article in Transfusion, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Genetic determinants of plasma testosterone in male blood donors are associated with altered red blood cell characteristics and survival in cold storage and after transfusion.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2024
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Johnson TranVitalant Research Institute, San Francisco, California, USA.ORCID 0000-0002-5263-6321
Rachael P JackmanVitalant Research Institute, San Francisco, California, USA.ORCID 0000-0001-8591-7819
Marcus O MuenchVitalant Research Institute, San Francisco, California, USA.ORCID 0000-0001-8946-6605
Kelsey HazeghVitalant Research Institute, Denver, Colorado, USA.
Scott-Wesley BeanVitalant Research Institute, Denver, Colorado, USA.
Kimberly A ThomasVitalant Research Institute, Denver, Colorado, USA.ORCID 0000-0001-8152-9974
Fang FangGenomics and Translational Research Center, RTI International, North Carolina, USA.
Grier PageGenomics and Translational Research Center, RTI International, North Carolina, USA.
Kim O'ConnorDepartment of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Nareg H RoubinianVitalant Research Institute, San Francisco, California, USA.
Bradley D AnawaltDepartment of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Tamir KaniasVitalant Research Institute, Denver, Colorado, USA.ORCID 0000-0001-6558-0913

Funding

Effect of blood donor sex and testosterone on predisposition to hemolysis in stored red blood cellsR01HL134653 · NHLBI · VITALANT · PI KANIAS, TAMIR · 2018 to 2022
$1.9M
NHLBI NIH HHS R01 HL134653
6 · The paper itself

Abstract

backgroundBlood collection from donors on testosterone therapy (TT) is restricted to red blood cell (RBC) concentrates to avoid patient exposure to supraphysiological testosterone (T). The objective of this study was to identify TT-related changes in RBC characteristics relevant to transfusion effectiveness in patients. STUDY

designThis was a two-part study with cohorts of patients and blood donors on TT. In part 1, we conducted longitudinal evaluation of RBCs collected before and at three time points after initiation of T. RBC assays included storage and oxidative hemolysis, membrane deformability (elongation index), and oximetry. In part 2, we evaluated the fate of transfused RBCs from TT donors in immunodeficient mice and by retrospective analyses of NIH's vein-to-vein databases.

resultsTT increased oxidative hemolysis (1.45-fold change) and decreased RBC membrane deformability. Plasma free testosterone was positively correlated with oxidative hemolysis (r = .552) and negatively correlated with the elongation index (r = -.472). Stored and gamma-irradiated RBCs from TT donors had lower posttransfusion recovery in mice compared to controls (41.6 ± 12 vs. 55.3 ± 20.5%). Recipients of RBCs from male donors taking T had 25% lower hemoglobin increments compared to recipients of RBCs from non-TT male donors, and had increased incidence (OR, 1.80) of requiring additional RBC transfusions within 48 h of the index transfusion event.

conclusionsTT is associated with altered RBC characteristics and transfusion effectiveness. These results suggest that clinical utilization of TT RBCs may be less effective in recipients who benefit from longer RBC survival, such as chronically transfused patients.

Indexed as

Blood PreservationErythrocyte DeformabilityErythrocytesErythrocyte TransfusionOxidative StressTestosteroneAdultAgedAnimalsBlood DonorsCell SurvivalFemaleHemolysisHumansMaleMiceTestosteroneblood donorshemolysistestosterone therapytransfusion effectiveness

Identifiers

PMID38884364
PMCPMC11316632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.